SVC compared with GANX: revenue, margins and what each company keeps, and the suppliers and customers both name

SVCService Properties Trust

Mkt capRevenueRevenue

GANXGain Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SVCService Properties Trust

GANXGain Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SVC: latest quarter is a loss; flow not drawable. GANX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SVC 32

AMCAMC Theatrescustomer

RMRRMRsupplier

—RMR (The RMR Group Inc.)unlistedsupplier

—Sonestaunlistedsupplier

28 more · SVC chain ›

Shared 0

No shared counterparties.

Only GANX 1

—Minoryx Therapeutics, S.Lunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

SVC, solidGANX, dashed

SVCService Properties Trust

6.17▼−1.22%· post 6.17

Mkt cap$804.3MRevenue$325MQ2 FY26Revenue$1.5BFY25

GANXGain Therapeutics, Inc.

1.16▲+2.34%· post 1.16

ClosedNov 3 '26

Mkt cap$49.3MRevenue—Revenue—

Compare

ClosedNov 3 '26

SVCService Properties Trust

GANXGain Therapeutics, Inc.

6.17▼−1.22%post 6.17

Price

1.16▲+2.34%post 1.16

$804.3M

Mkt cap

$49.3M

Q2 FY26$325M

Revenue

—

FY25$1.5B

Revenue

—

SVC6.17▼−1.22%vsGANX1.16▲+2.34%ClosedNov 3 '26